Roundtable on Diversity in Clinical Trial Enrollment

The DEI Task Force held a Corporate Member Roundtable on November 12, 2022, with key stakeholders including Industry (pharmaceutical and biotech companies), the FDA and SITC leadership.

Organized by Leisha Emens, MD, PhD, Padmanee Sharma, MD, PhD, and John H. Stewart, IV, MD, MBA, FACS, the roundtable aimed to create a discussion with the FDA Guidance on diversity in clinical trial enrollment, elucidate questions and challenges key stakeholders have in implementing the guidance, and facilitate a conversation with these key stakeholders to provide clarity and direction. 

Read the Executive Summary

To build on the learnings from the November 2022 Roundtable, the Organizers will host a virtual Roundtable on Diversity in Clinical Trial Enrollment on July 25, 2023. The goal of the virtual Roundtable is to walk away with recommendations for specific actions each stakeholder in the clinical trial ecosystem can take to positively impact diversity in clinical trial enrollment. Representatives from each stakeholder group will participate in the roundtable, which will consist of a series of presentations and panels that highlight success stories and lessons learned in addressing implicit bias challenges, creating patient and community engagement and optimizing trial designs and operations that facilitate access to clinical trials for patients of diverse backgrounds. By enabling a conversation across stakeholders, SITC aims to carve a roadmap for next steps each stakeholder group can take to increase diversity in all immuno-oncology clinical trials.

Learn more and Register

DEI Strategic Plan Focus

Workforce Pipeline

From Early Career through Leadership

New Early Career Scientist Efforts >

Existing Early Career Scientist Efforts >

Leadership Efforts >

Research & Patient Access

Clinical Trial Diversity and Equitable Patient Access

Landscape Analysis >

Collaborate >

Crisis in Clinical Research >

Workforce Pipeline: Existing Early Career Scientist Efforts

Women in Immunotherapy Network (WIN) Leadership Institute

• Travel Awards
• Expand DEI content
• Explore WIN >

Sparkathon

• Expand DEI content
• Explore Sparkathon >

Hybrid and Virtual Programs Increase Access

• Winter School >
• Spring Scientific >
• Annual Meeting >
  
• Webinars >

Membership and Registration Discounts

• LMICs
• Financial Hardships

Workforce Pipeline: New Early Career Scientist Efforts

STEM Undergrad Program for URGs

• 1-day, curated program at Annual Meeting
• First program at SITC 2022
• Watch Preview >

Travel Awards for Underrepresented Groups

• For ECS
• For all SITC programs

DEI Fellowships

• DEI and Women Fellowships
• Goal: Offer Annually

Educational Programs at HBCUs

• Educational programs at historically black and Hispanic colleges and universities
• Long Term Goal

Workforce Pipeline: Leadership

Mentorship Program

• Partner a senior leader with an early career person during the Annual Meeting to extend longitudinally

DEI Positioned Purposefully

• Collecting race/ethnicity data
• Website section to feature diverse membership
• Global diversity
• Landscape analyses

Diversity in SITC Faculty, Committees, Board

• Ensure diverse slate of speakers, committee members, and election candidates

Listening Sessions & Diversity Panels

• 2021: Asian and Pacific Islander
• 2022: Black and African American

Clinical Trial Diversity and Equitable Patient Access

Landscape Analysis

• Professional societies, government agencies, Industry; to ensure a lack of duplicity and find gaps in clinically oriented DEI programs
• Long Term

Collaborate

• With like-minded stakeholders in academic, NIH/NCI, FDA, pharma based on outputs related to patient care/clinical trials
• Long Term

Crisis in Clinical Research

• Partner/parallel work with outputs stemming from August 17 Summit